News for Healthier Living

A Way to 'Unstick' Cancer's Glue? How Experimental Drug FL118 Disrupts Tumor Survival Networks

Writing in the Journal of Experimental & Clinical Cancer Research, scientists from Roswell Park report that the investigational anticancer agent FL118 functions as a dual molecular glue degrader that directly targets and degrades two emerging therapeutic targets.

August 7, 2026


August 19 2026

August 18 2026

August 17 2026

August 16 2026

August 15 2026

August 14 2026

August 13 2026

August 12 2026

August 11 2026

August 10 2026

August 7 2026

August 6 2026

August 5 2026